The Relevant Disclosure is Attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Malar Hospitals has informed the BSE that the tenure of Mr. Ramesh Lakshman Adige as a Non-Executive Non-Independent Director ends on May 5, 2025. The Board, via resolution by circulation on May 2, 2025, approved the appointment of Dr. Ritu Garg in his place, effective May 6, 2025. Dr. Garg, aged 46, is an ENT surgeon with an ISB Hyderabad management degree and over a decade of experience at Fortis Healthcare, where she previously led the Fortis Memorial Research Institute. She is not debarred by SEBI and is not related to any existing director on the board.
This is a routine board-level change driven by end-of-tenure of an existing director, with a Fortis-network insider stepping in. No material impact on operations or shareholders is expected, though it reinforces the promoter group's continued representation on the Fortis Malar board.